They observed focal CTRP6 immunoreactivity in tumor regions with minimal fibrosis, whereas most cancer cells at the invasive front were CTRP6-negative, particularly in areas of extensive fibrosis. The gene discussed is C1QTNF6; the disease is neoplasm.